Study identifies those at high risk for developing pancreatic cancer
the ONA take:
According to new findings published in the journal Digestive and Liver Diseases, an international team of researchers has developed a profile of the patient who would be at highest risk for developing pancreatic lesions that are most likely to develop into cancer.
To determine which patients are at high risk, the researchers analyzed data from 1,126 patients diagnosed with pancreatic lesions.
Of those, 84 developed invasive pancreatic cancer. Results showed that all 84 patients had all or some of the following factors: a history of smoking, a history of obesity, jaundice, and steatorrhea.
Researchers also identified the following risk factors: a larger cyst size, cysts in the main pancreatic duct, and nodules on the cyst wall. The study showed that abdominal pain did not put patients at high risk.
The authors estimate that between 10 and 40% of people have these lesions, but the majority do not develop pancreatic cancer.
The findings may help assure concerned patients who have these lesions that they are not at high risk for developing pancreatic cancer.
Researchers developed a profile of the patient who would be at highest risk for developing pancreatic lesions.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|